Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2005 Mar 18;64(10):1490–1493. doi: 10.1136/ard.2004.032813

Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome

I Krause 1, S Lev 1, A Fraser 1, M Blank 1, M Lorber 1, L Stojanovich 1, J Rovensky 1, J Chapman 1, Y Shoenfeld 1
PMCID: PMC1755247  PMID: 15778242

Abstract

Background: Heart valves lesions and central nervous system involvement are among the most common manifestations of the antiphospholipid syndrome (APS).

Objective: To evaluate possible interrelations between these manifestations in a large group of APS patients.

Methods: 284 APS patients were evaluated retrospectively, 159 of whom had primary APS. Cardiac–CNS associations were determined for the entire study population, and for subgroups of patients with primary APS or APS associated with systemic lupus erythematosus (SLE).

Results: Significant associations where found between cardiac vegetations and epilepsy (p<0.02), and between cardiac valve thickening or dysfunction and migraine (p = 0.002). Borderline association was found between valvar vegetations and migraine (p = 0.09). A significant association was also found between all valvar lesions and stroke or transient ischaemic attacks. Subanalyses showed that patients with primary APS had significant associations between cardiac valve pathology and all CNS manifestations, while patients with APS associated with SLE had no such associations.

Conclusions: The study suggests potential differences in biological behaviour between primary APS and APS associated with SLE. The presence of cardiac valve pathology may be a risk factor for several types of CNS involvement in PAPS.

Full Text

The Full Text of this article is available as a PDF (65.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Afek A., Shoenfeld Y., Manor R., Goldberg I., Ziporen L., George J., Polak-Charcon S., Amigo M. C., Garcia-Torres R., Segal R. Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome. Lupus. 1999;8(7):502–507. doi: 10.1191/096120399678840873. [DOI] [PubMed] [Google Scholar]
  2. Alarcón-Segovia D., Delezé M., Oria C. V., Sánchez-Guerrero J., Gómez-Pacheco L., Cabiedes J., Fernández L., Ponce de León S. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989 Nov;68(6):353–365. doi: 10.1097/00005792-198911000-00003. [DOI] [PubMed] [Google Scholar]
  3. Alarcón-Segovia Donato. The antiphospholipid story. J Rheumatol. 2003 Sep;30(9):1893–1896. [PubMed] [Google Scholar]
  4. Amital H., Langevitz P., Levy Y., Afek A., Goldberg I., Pras M., Livneh A., Shoenfeld Y. Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. Clin Exp Rheumatol. 1999 Jan-Feb;17(1):99–102. [PubMed] [Google Scholar]
  5. Asherson R. A., Khamashta M. A., Ordi-Ros J., Derksen R. H., Machin S. J., Barquinero J., Outt H. H., Harris E. N., Vilardell-Torres M., Hughes G. R. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989 Nov;68(6):366–374. [PubMed] [Google Scholar]
  6. Barbut D., Borer J. S., Gharavi A., Wallerson D., Devereux R. B., Supino P., Suite N. D. Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events. Am J Cardiol. 1992 Oct 1;70(9):901–905. doi: 10.1016/0002-9149(92)90735-h. [DOI] [PubMed] [Google Scholar]
  7. Cervera R., Khamashta M. A., Font J., Reyes P. A., Vianna J. L., López-Soto A., Amigo M. C., Asherson R. A., Azqueta M., Paré C. High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndrome. Lupus. 1991 Nov;1(1):43–47. doi: 10.1177/096120339100100108. [DOI] [PubMed] [Google Scholar]
  8. Cervera R. Recent advances in antiphospholipid antibody-related valvulopathies. J Autoimmun. 2000 Sep;15(2):123–125. doi: 10.1006/jaut.2000.0405. [DOI] [PubMed] [Google Scholar]
  9. Cervera Ricard, Piette Jean-Charles, Font Josep, Khamashta Munther A., Shoenfeld Yehuda, Camps María Teresa, Jacobsen Soren, Lakos Gabriella, Tincani Angela, Kontopoulou-Griva Irene. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002 Apr;46(4):1019–1027. doi: 10.1002/art.10187. [DOI] [PubMed] [Google Scholar]
  10. Chapman J., Cohen-Armon M., Shoenfeld Y., Korczyn A. D. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus. 1999;8(2):127–133. doi: 10.1191/096120399678847524. [DOI] [PubMed] [Google Scholar]
  11. Chapman J., Rand J. H., Brey R. L., Levine S. R., Blatt I., Khamashta M. A., Shoenfeld Y. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus. 2003;12(7):514–517. doi: 10.1191/0961203303lu392oa. [DOI] [PubMed] [Google Scholar]
  12. Cuadrado M. J., Khamashta M. A., Hughes G. R. Migraine and stroke in young women. QJM. 2000 May;93(5):317–318. doi: 10.1093/qjmed/93.5.317. [DOI] [PubMed] [Google Scholar]
  13. Galve E., Ordi J., Barquinero J., Evangelista A., Vilardell M., Soler-Soler J. Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med. 1992 Feb 15;116(4):293–298. doi: 10.7326/0003-4819-116-4-293. [DOI] [PubMed] [Google Scholar]
  14. García-Torres R., Amigo M. C., de la Rosa A., Morón A., Reyes P. A. Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings. Lupus. 1996 Feb;5(1):56–61. doi: 10.1177/096120339600500111. [DOI] [PubMed] [Google Scholar]
  15. Hojnik M., George J., Ziporen L., Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996 Apr 15;93(8):1579–1587. doi: 10.1161/01.cir.93.8.1579. [DOI] [PubMed] [Google Scholar]
  16. Hughes G. R. V. Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome. Postgrad Med J. 2003 Feb;79(928):81–83. doi: 10.1136/pmj.79.928.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hughes G. R., Harris N. N., Gharavi A. E. The anticardiolipin syndrome. J Rheumatol. 1986 Jun;13(3):486–489. [PubMed] [Google Scholar]
  18. Lev Shaul, Shoenfeld Yehuda. Cardiac valvulopathy in the antiphospholipid syndrome. Clin Rev Allergy Immunol. 2002 Dec;23(3):341–348. doi: 10.1385/CRIAI:23:3:341. [DOI] [PubMed] [Google Scholar]
  19. Levine Jerrold S., Branch D. Ware, Rauch Joyce. The antiphospholipid syndrome. N Engl J Med. 2002 Mar 7;346(10):752–763. doi: 10.1056/NEJMra002974. [DOI] [PubMed] [Google Scholar]
  20. Nesher G., Ilany J., Rosenmann D., Abraham A. S. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum. 1997 Aug;27(1):27–35. doi: 10.1016/s0049-0172(97)80034-0. [DOI] [PubMed] [Google Scholar]
  21. Pamuk O. N., Cakir N., Soy M., Aktoz M., Celik Y., Akdemir O. Mitral valve vegetation and cerebral emboli in a primary antiphospholipid syndrome patient who had hepatitis C virus infection: report of a case and review of the literature. Clin Rheumatol. 2003 May;22(2):136–139. doi: 10.1007/s10067-002-0662-5. [DOI] [PubMed] [Google Scholar]
  22. Peltola J. T., Haapala A., Isojärvi J. I., Auvinen A., Palmio J., Latvala K., Kulmala P., Laine S., Vaarala O., Keränen T. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am J Med. 2000 Dec 15;109(9):712–717. doi: 10.1016/s0002-9343(00)00617-3. [DOI] [PubMed] [Google Scholar]
  23. Petri Michelle A. Classification criteria for antiphospholipid syndrome: the case for cardiac valvular disease. J Rheumatol. 2004 Dec;31(12):2329–2330. [PubMed] [Google Scholar]
  24. Pope J. M., Canny C. L., Bell D. A. Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant. Am J Med. 1991 Mar;90(3):299–309. [PubMed] [Google Scholar]
  25. Sanna G., Bertolaccini M. L., Cuadrado M. J., Khamashta M. A., Hughes G. R. V. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford) 2003 Feb;42(2):200–213. doi: 10.1093/rheumatology/keg080. [DOI] [PubMed] [Google Scholar]
  26. Shoenfeld Y. Systemic antiphospholipid syndrome. Lupus. 2003;12(7):497–498. doi: 10.1191/0961203303lu396xx. [DOI] [PubMed] [Google Scholar]
  27. Shoenfeld Yehuda, Lev Shaul, Blatt Ilan, Blank Miri, Font Joseph, von Landenberg Philipp, Lev Nirit, Zaech Joseph, Cervera Ricard, Piette Jean-Charles. Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol. 2004 Jul;31(7):1344–1348. [PubMed] [Google Scholar]
  28. Sun K. H., Liu W. T., Tsai C. Y., Liao T. S., Lin W. M., Yu C. L. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann Rheum Dis. 1992 Jun;51(6):707–712. doi: 10.1136/ard.51.6.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Vianna J. L., Khamashta M. A., Ordi-Ros J., Font J., Cervera R., Lopez-Soto A., Tolosa C., Franz J., Selva A., Ingelmo M. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med. 1994 Jan;96(1):3–9. doi: 10.1016/0002-9343(94)90108-2. [DOI] [PubMed] [Google Scholar]
  30. Wilson W. A., Gharavi A. E., Koike T., Lockshin M. D., Branch D. W., Piette J. C., Brey R., Derksen R., Harris E. N., Hughes G. R. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999 Jul;42(7):1309–1311. doi: 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  31. Zavaleta Nilda Espinola, Montes Rosa María, Soto María Elena, Vanzzini Nidia Avila, Amigo Mary-Carmen. Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study. J Rheumatol. 2004 Dec;31(12):2402–2407. [PubMed] [Google Scholar]
  32. Ziporen L., Goldberg I., Arad M., Hojnik M., Ordi-Ros J., Afek A., Blank M., Sandbank Y., Vilardell-Tarres M., de Torres I. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus. 1996 Jun;5(3):196–205. doi: 10.1177/096120339600500306. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES